Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Some index funds distribute fewer capital gains than others, which can reduce tax surprises and improve after-tax performance over time.
28,126 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
What if the best gains come from stocks you didn’t expect? This guide shows how unexpected stock picks looking ahead ...
A teacher faces a tempting lump-sum move to boost pension benefits. Experts warn that a $50,000 IRA decision may trap...
XRP remains in a tight battle between support and supply as July markets unfold. A breach of key levels could set XR...
A small, less-known U.S. LNG exporter is emerging as a potential winner as Europe faces a gas crunch amid Middle East...
Palantir stock has fallen from its all-time high, but a fall doesn’t mean a free pass to buy. This guide breaks down ...
After a quarterly report, Netflix's post-earnings sell-off just highlighted a shift in strategy. This article breaks ...
Orion Group stock dropped experienced intraday swings, illustrating how earnings, guidance, and market sentiment can ...
IMAX stock jumped this week as takeover chatter surfaced. This article breaks down the drivers behind the move, what ...
A leading MIT AI researcher warns that rushing automation in Gen Z entry-level roles could undermine on-the-job learn...
XRP has stabilized near $1.30, with a supply wall and on-chain behavior buffering downside. The piece breaks down wha...
A broad rally in memory stocks follows a strong Micron session, lifting SanDisk and Western Digital as AI datacenter ...